TrialSignal
Clinical trial intelligence report
Biomarker-guided Diagnosis of Tuberculosis
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Aug 04, 2026
Report code
NCT07125274-Aug 04, 2026
NCT ID
NCT07125274
Status
RECRUITING
Phase
registry-stage
Sponsor
Research Center Borstel
Executive brief
Investment-Ready Snapshot
Biomarker-guided Diagnosis of Tuberculosis is a registry-stage clinical asset sponsored by Research Center Borstel in Tuberculosis. SEO and diligence focus: Biomarker-guided diagnostic tests, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT07125274
Indication
Tuberculosis
Modality
RNA therapy
Target
Biomarker-guided diagnostic tests
Intervention
Biomarker-guided diagnostic tests
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.